A Europe-wide marijuana legalization initiative campaign is underway, a Republican legalization group will hold its first meeting in Texas, there's still a California legalization initiative trying to make the ballot this year, state legislatures deal reflexively with familiar drug issues, and more. Let's get to it:
[image:1 align:left caption:true]Marijuana Policy
DC Election Board Hears Arguments to Allow Legalization Initiative on Ballot. The District of Columbia Board of Elections heard proponents of a DC legalization initiative argue Tuesday that they should okay the measure for the ballot. The hearing comes days after DC Attorney General Irvin Nathan urged the board to reject the measure because it would conflict with a provision of federal law requiring that residents of public housing be evicted for drug possession. Nathan's opinion is not binding. The board said it would act on the matter within a week.
One California Legalization Initiative Remains and is Seeking $2 Million. And then there was one. The California Cannabis Hemp Initiative has fallen short of its signature-gathering goal and will not make the ballot this year. The Drug Policy Alliance-backed initiative has been set aside for this year, and the Ed Rosenthal initiative designed as an alternative to it, has now likewise been set aside. That leaves only the Marijuana Control, Legalization & Revenue Act, which has until April 18 to gather more than 500,000 valid voter signatures. San Jose dispensary operator and initiative proponent Dave Hodges said the campaign needs $2 million to gather those signatures, and it is still doable. Click on the link for more details.
Republicans Against Marijuana Prohibition to Hold First Meeting in Houston. Yeah, you read that right. Republicans Against Marijuana Prohibition, a national caucus founded in 2012 by Ann Lee, mother of Oaksterdam's Richard Lee, will host its inaugural meeting March 15 in Houston. Click on either link for more details.
New Georgia Poll Has Majority for Legalization. A new Public Policy polling survey finds that 54% of Georgia voters want to see marijuana legalized for recreational use. Support for decriminalization was at 62%. Click on the survey link for further demographic info.
Fed Delay in Supplying Marijuana Blocks PTSD Research. The US Public Health Service (PHS) is blocking researchers who are seeking to learn more about the risks and benefits of using marijuana to treat PTSD, the Multidisciplinary Association for Psychedelic Studies (MAPS) said Monday. A Food and Drug Administration (FDA) and University of Arizona Institutional Review Board (IRB)-approved protocol for a study of marijuana for symptoms of PTSD in US veterans, sponsored by MAPS, has been on hold for over 3½ months, as researchers wait for the PHS to respond to their request to purchase marijuana for the study. The study would explore the safety and effectiveness of smoked and/or vaporized marijuana for 50 U.S. veterans with chronic, treatment-resistant PTSD. Animal studies have already shown that marijuana helps quiet an overactive fear system, but no controlled clinical studies have taken place with PTSD patients. The PHS marijuana review process exists only because the National Institute on Drug Abuse (NIDA) has a Drug Enforcement Administration (DEA)-protected monopoly on the supply of marijuana legal for use in FDA-regulated research. This additional review is not required for research on any other Schedule I drug.
Tampa Medical Marijuana Debate Gets Rowdy. Tampa Bay area residents got an earful at a debate over medical marijuana Monday night. Local news reports said there was "screaming, yelling, and even people dragged out" as Alan St. Pierre of NORML and Florida attorney John Morgan, the man behind the state's medical marijuana initiative, squared off against Kevin Sabet of Project SAM and prehistoric prohibitionist Dr. Eric Voth.
Georgia CBD Medical Marijuana Bill Stalled in Committee. A bill that would allow for the use of CBD cannabis oil to treat epileptic seizures in children is stuck in committee as lawmakers grapple with the issue of how to obtain it. Either growing it or importing it would violate state law. The bill is House Bill 885, which is stuck in the House Health and Human Services Committee.
Oregon Dispensary Regulation Bill Amended to Allow Local Bans. The Oregon bill to legalize and regulate dispensaries statewide, Senate Bill 1531, was amended in a Senate committee vote to allow localities to not just regulate dispensaries, but to ban them. The bill has passed the Senate and is now before the House Judiciary Committee. The statewide dispensary regulation system is scheduled to begin March 3.
Michigan Bills to Restrict Pseudoephedrine Purchases Moving. A package of bills designed to crack down on the use of pseudoephedrine in the manufacture of meth passed the state Senate last week. They would ban the sale of the chemical to people with meth convictions and make it a 10-year felony to buy the stuff knowing it's intended to make meth. The bills, sponsored by Sen. John Proos (R-St. Joseph) are Senate Bill 535, Senate Bill 563, Senate Bill 564, and Senate Bill 756.
Oklahoma Prescription Drug Database Bill Moving. A bill that would require doctors to check an online prescription database before prescribing drugs with abuse potential passed the Senate Health and Human Services Committee Monday. Senate Bill 1821, sponsored by Sen. A.J. Griffin (R-Guthrie) now heads for a Senate floor vote.
European "Weed Like to Talk" Citizens' Initiative Underway. In the European Union, voters can submit "citizen initiatives" that require EU legislators to propose legislation if they reach a million signatures. The "Weed Like to Talk" initiative began collecting signatures last week for an effort to legalize marijuana. It has about 35,000 signatures so far. Click here to see a by-country count.
Chronicle Book Review: Meth Mania: A History of Methamphetamine by Nicholas Parsons (2014, Lynne Reinner Publishers, 241 pp., $58.50 HB)
[image:1 align:right]What is the "drug menace" du jour? Crack cocaine? Nah, been there, done that. Bo-ring. Marijuana? Some people still try to find scary things to say about pot, but it just doesn't seem to really resonate anymore. Meth? Been there, done that, too, several times, as you'll see below.
Heroin seems to be a good candidate. After all, if you read the newspapers, especially after a celebrity overdose death, you'll know there's an "epidemic" of heroin use (and related overdose deaths) happening. Except that, while heroin use has increased in the last few years (primarily as a consequence of crackdowns on opioid pain pills), it is hardly an "epidemic." According to the National Survey on Drug Use and Health, the number of people using heroin on a regular is one-tenth of one percent of the population 12 and over. That number stayed stable from 2010 to 2012, the last year available for the survey, although it has apparently increased somewhat since then. And while overdoses are up, they are nowhere near the number of deaths for prescription pills.
But heroin, too, is old hat. One of the elements of a good drug panic is novelty. On that count, both "bath salts" (synthetic stimulants derived from cathinones) and "Molly" (a powder form of MDMA) are contenders for the crown. There's nothing like a zombie cannibal ripping someone's face off to propel a good drug panic, as was the case with bath salts, even if he didn't actually eat the guy's face and even, as it turned out, if he wasn't on bath salts.
While bath salts users are portrayed as scary insane people who aren't us, Molly users, on the other hand, are our sons and daughters, the innocent victims of evil drug dealers. Innocent victimhood is always good in whipping up a drug panic.
But again, the number of people actually consuming bath salts and Molly is miniscule. By far the biggest psychoactive drug problem in America, in terms of effects on the health of consumers, adverse impacts on others, and criminal justice system impacts, is alcohol. Yet, somehow, the country's most widely used and misused drug doesn't merit the screaming headlines, the hyperbole, the hysteria, and the hand-wringing. Why is that?
In Meth Mania, Nicholas Parsons provides some hints of an answer. While the book delivers what its title promises -- a critical history of meth, written with verve and insight -- it is also an exercise in applying the framework of social constructionism to the way we define and create social problems in general and drug panics in particular. Social constructionists, Parsons explains, attempt to understand how, why, and when certain social phenomenon come to be defined as social problems.
At any given moment, there are a panoply of issues -- child abuse, pornography, homosexuality, drug use, poverty, inequality, among others -- that could be defined as social problems. And social problems require solutions, darn it, otherwise, they wouldn't be problems. What social problems also require is someone to define them as such.
For Parsons and the social constructionists, these people are "claims makers." To be an effective claims maker, you must be credible and you must have access to the media. When it comes to drugs and drug policy, claims makers have traditionally been law enforcement, the medical profession, scientists, and moral entrepreneurs -- individuals or groups who seek power or influence by defining a phenomenon as a social problem and offering to do something about it. (I would posit that the advances we have seen in drug reform are, to some degree, the result of decades of work to both create alternate credible claims makers to cast the debates in new terms and to undermine the credibility ot traditional drug policy claims makers.)
Parsons is especially interesting in his discussion of law enforcement as a claims maker when it comes to drugs. Not only do police have authority and credibility as protectors of the public safety, they also have well-developed PR departments (although they don't call them that) that are constantly churning out press releases, er, I mean crime and arrest reports, they have very close and easy, and long-standing access to the media.
And, of course, law enforcement has its own interests to protect. Parsons notes one particularly brazen example of self-interested panic purveying, the "ice" scare of the late 1980s. The DEA jumped all over that -- until its annual budget was secured, then not so much.
This leads me to something Parsons didn't discuss, but which I have long wondered: Why, exactly, are police considered experts on drugs? Because they arrest drug users? Police arrest domestic violence suspects, too, but that doesn't make them experts on domestic bliss, as their own divorce and domestic assault rates indicate.
Parsons identifies three distinct meth panics -- the Speed Kills! methedrine panic of the late 1960s and early 1970s, the abortive "ice" panic of the late 1980s, and the meth panic that began near the end of the century and peaked around 2005, although its lingering effects still persist. In all three cases, although less clearly so in the latter, Parsons crunches the numbers on meth use and finds that the panics are related less to actual use rates than to media attention paid to the drug. And media attention paid to the drug is likewise driven not so much by actual use as by claims makers managing to get traction for their claims, for a variety of reasons.
Parsons is also good at elaborating how we construct "folk devils" on which to hang our anxieties, and how those folk devils have changed over time. This is the stuff of stereotyping and Othering. Meth users are "zombie McGyvers," tweaked-out tinkerers who haunt Walmarts in the middle of the night. Or they are -- gasp! -- gay nightclub orgiasts in New York City. That's when they're the Other.
In some adumbrations of meth panic, users shift from the scary Other to the innocent victim, who fall prey to evil Other drug dealers. And it's even more helpful when scary Other drug suppliers have brown skins, like the Mexican drug cartels who, in the wake of various moves to repress domestic meth production, such as the current effort in West Virginia to make OTC cold medications containing pseudoephedrine prescription only, have taken an ever-increasing share of the US meth market.
I refer to those bills generically as "The Mexican Methamphetamine Market Share Enhancement Act," and Parsons makes a similar point: All of the efforts to repress the use and manufacture of meth have had unintended consequences that in most cases have only exacerbated the problems they were supposedly designed to solve. The imposition of controls on prescription meth and other amphetamines in the late 1960s led directly to the first round of outlaw biker-manufactured meth, and the switch from "eatin' speed" to "shootin' speed." They probably also played a role in the expansion of cocaine and crack use in the 1970s and 1980s.
Restrictions on precursor chemicals used in the P2P method led to the explosion of pseudoephedrine-based meth cooking. And continuing and deepening restrictions on meth and precursors have created the space for the new synthetic stimulants, the so-called bath salts, whose effects can be even more intense than meth.
The latest meth panic may be receding, but its effects linger. People making small amounts of meth for personal use in the one-pot method are still being arrested and sentencing as if they were major drug lab operators. New anti-meth laws still emerge at statehouses each year. And people who use meth are still demonized as if far outlier worst cases are the normal meth experience.
Meth Maniais an excellent history of America's love-hate affair with its premier stimulant drug, but it is also a guidebook for deconstructing the making of drug panics in general. As such, its value extends far beyond a single drug. This one needs to be on the bookshelf of any serious drug and drug policy student.
In a new report released this week, neuroscientist Dr. Carl Hart and coauthors Joanne Csete and Don Habibi examines common assumptions about methamphetamine use and users and finds them wanting. Instead of careful, evidence-based analysis, rising concern about meth use has resulted in "a barrage of misinformation and reckless policies," Hart finds.
"The scientific literature on methamphetamine is replete with unwarranted conclusions, which has provided fuel for the implementation of draconian drug policies that exacerbate problems faced by poor people," said Hart.
As its title suggests, the report, Methamphetamine: Fact vs. Fiction and Lessons from the Crack Hysteria, finds clear parallels between the tide of distorted facts, faulty assumptions, and misinformation that characterized the crack cocaine scare of the early 1980s and similar claims made about the most recent drug panic over methamphetamine. Both feature the same sorts of claims, made by the same sorts of claims makers -- largely police, health professionals, and academics.
While the report finds real detrimental health effects with sustained meth use, it says those effects are exaggerated and/or the result of factors other than meth use in or by itself, such as poor overall health, poor nutrition, poor dental care, and poverty. It also challenges claims that meth is more powerfully addictive than other drugs.
In the report, Hart calls on lawmakers at home and abroad to revisit laws that harshly punish methamphetamine possession, to invest in treatment instead of punishment, to reconsider restrictions on access to amphetamines for legitimate medical purposes, and to stop supporting "wasteful and ineffective" scare campaigns replete with misinformation about meth use.
"We've been down this road before with other drugs that were poorly studied and misrepresented by media," said Kasia Malinowska-Sempruch, director of the Open Society Global Drug Policy Program. "The results included policies that hurt the users, ineffectively addressed the problem and ultimately failed society. We can't afford to repeat these experiences."
NORML endorses a US Senate candidate, pressure mounts for medical marijuana in New York, West Virginia wants to make Sudafed prescription only, and more. Let's get to it:
[image:1 align:right caption:true]Marijuana Policy
Arizona Poll Has 51% for Legalization. A poll from Arizona's Behavior Research Center has support for marijuana legalization at 51%, with 41% opposed. In recent months, other polls have showed majorities both for and against legalization.
Maine US Senate Candidate Wins NORML PAC Endorsement. NORML PAC, NORML's political campaign arm, has endorsed Shenna Bellows in her campaign to represent Maine in the US Senate. "Shenna Bellows has been at the forefront of the fight for marijuana legalization even before beginning this campaign," stated NORML PAC Manager Erik Altieri, "During her tenure leading the Maine ACLU, Shenna has demonstrated she has the skill and determination to fight for sensible reforms and has proven to be a vocal and articulate leader in calling for the end of marijuana prohibition. We believe she will be invaluable in the United States Senate to help move the country away from our failed war on marijuana and towards a new, smarter approach." Bellows is seeking the Democratic Party nomination.
Almost Nine Out of Ten New Yorkers Support Medical Marijuana, Poll Finds.A new Quinnipiac poll has support for medical marijuana at 88%, with only 9% opposed. The poll also had a 57% majority for marijuana legalization. Click on the link for more poll details.
Two New York GOP State Senators Announce Support for Medical Marijuana Bill. Two Republican state senators, George Maziarz (R-Newfane) and Mark Grisanti (R-IP-Buffalo), have announced their support for the pending medical marijuana bill, the Compassionate Care Act. They are the first Republicans to do so. The Compassionate Care Act has passed the Assembly four times, and Governor Cuomo's administration has said the governor would sign it, but the legislation has long been stuck in the Senate.
Oregon Bill to Block Cities and Counties from Banning Dispensaries Passes Senate. The Oregon Senate Tuesday passed Senate Bill 1531, which would let cities and counties regulate medical marijuana dispensaries, but not ban them. A number of cities have already passed ordinances banning dispensaries before a new state law allowing them goes into effect next month, and the Association of Oregon Cities is threatening to sue if the bill passes. It now goes to the House.
New Mexico Patient Survey Finds Program Not Providing Enough Medical Marijuana. A state Department of Health survey of patients enrolled in the state's medical marijuana program finds that only about 20% of patient demand is being met through legal channels. Licensed growers are producing about 2,250 pounds a year, but the survey put the annual demand from patients at more than 11,000 pounds. The Health Department is now "weighing its options about whether to increase production" and whether to increase the number of producers or the number of plants each can produce, a spokesman said.
Indiana Food Stamp Drug Test Bill Now Targets Only Those With Misdemeanor Drug Convictions. A bill that would have required drug screening for all food stamp applicants and drug testing for those deemed likely to be using has been amended to now apply only to people who have misdemeanor drug convictions in the past 10 years. (People with drug felonies are ineligible for food stamps under a federal law that Indiana has not opted out of.) House Bill 1351 passed the Senate Health and Provider Services Committee after being amended. It has already passed the House.
Bill Making Sudafed Prescription-Only Passes West Virginia Senate. A bill that would make access to OTC cold medications containing pseudoephedrine available by prescription only passed the state Senate Tuesday. Senate Bill 6 now goes to the House. The measure is aimed at reducing the number of meth labs in the state, although it has had only temporary effects in the other two states where it has been adopted. Pseudoephredrine is a precursor chemical in meth manufacture.
Georgia to Ban Synthetic Cannabinoid Chemicals. Georgian Minister of Labor, Health and Social Affairs Davit Sergeenko said Wednesday a law on criminalizing the basic biochemical formulas used to create synthetic cannabis has been almost completed. "From now on, these substances will be considered as illegal and all the control mechanisms and limits that are set on other legal or illegal drugs will be valid for synthetic cannabis too," Sergeenko said.
Myanmar Extends Opium Crop Substitution Program in Northern Shan State. The Myanmar government, working in cooperation with the UN Office on Drugs and Crime, is extending its crop substitution program for poppy farmers in Northern Shan State. The idea is to increase farmers' food security in areas where eradication has taken place. Last year, Myanmar eradicated about one-fifth of the estimated poppy crop.
(This article was published by StoptheDrugWar.org's lobbying arm, the Drug Reform Coordination Network, which also shares the cost of maintaining this web site. DRCNet Foundation takes no positions on candidates for public office, in compliance with section 501(c)(3) of the Internal Revenue Code, and does not pay for reporting that could be interpreted or misinterpreted as doing so.)